Thalassemia trait and arterial thromboembolic events: A systematic review and a meta-analysis of the literature

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 5, 2011, Pages 917-921

  Dentali, F ^a   Romualdi, E ^a   Ageno, W ^a   Cappellini, M D ^b   Mannucci, P M ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

thalassemia trait; Arterial thrombosis; Cardiovascular disease

Indexed keywords

ACUTE HEART INFARCTION; ARTERIAL THROMBOEMBOLISM; ARTICLE; BETA THALASSEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; EMBASE; HUMAN; MEDLINE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMATIC REVIEW; THROMBOEMBOLISM;

BETA-THALASSEMIA; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; ODDS RATIO; RESEARCH DESIGN; RISK FACTORS; THROMBOEMBOLISM;

EID: 79955662246     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04253.x     Document Type: Article

References (26)

1. Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol 2004; 26: 159-76.
2. Taher AT, Otrock ZK, Uthman I, Cappellini MD. Thalassemia and hypercoagulability. Blood Rev 2008; 22: 283-92.
3. Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and betathalassemia. Thromb Haemost 1996; 76: 322-7.
4. Winichagoon P, Fucharoen S, Wasi P. Increased circulating platelet aggregates in thalassaemia. Southeast Asian J Trop Med Public Health 1981; 12: 556-60.
5. Bareford D, Stone PCW, Cirling AJ, Gyde OHB, Stuart J. Effect of microcytosis on erythrocyte rheology. Clin Hemorheol 1988; 8: 197-9.
6. Fessas P, Stamatoyannopoulos G, Keys A. Serum cholesterol and thalassemia trait. Lancet 1974; 2: 1182-3.
7. Kolata G. Lower cholesterol decreases heart disease. Science 1984; 223: 381-2.
8. Elwood PC, Waters EE, Benjamin IT, Sweetnam PM. Mortality and anaemia in woman. Lancet 1974; 1: 891-4.
9. Carter C, McCee D, Dwayne R. Hematocrit and the risk of coronary heart disease: the Honolulu heart program. Am Heart J 1983; 105: 674-9.
10. McGinn T, Wyer PC, Newman TB, Keitz S, Leipzig R, For GG, for Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004; 171: 1369-73.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
13. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in metaanalysis. BMJ 2001; 323: 101-5.
14. Crowley JP, Sheth S, Capone RJ, Shilling RF. A paucity of thalassemia trait in Italian men with myocardial infarction. Acta Haematol 1987; 78: 249-51.
15. Gallerani M, Scapoli C, Cicognani I, Ricci A, Martinelli L, Cappato R, Manfredini R, Dall'ara G, Faggioli M, Pareschi PL. Thalassemia trait and myocardial infarction: low infarction incidence in male subjects confirmed. J Intern Med 1991; 230: 109-11.
16. Gulati R, Gambhir D, Garg N, Agarwal S. Does beta thalassemia confer protection against coronary artery disease. J Intern Med India 2001; 4: 171-3.
17. Hashemi M, Shirzadi E, Talaei Z, Moghadas L, Shaygannia I, Yavari M, Amiri N, Taheri H, Montazeri H, Shamsolkottabi H. Effect of heterozygous β-thalassemia trait on coronary atherosclerosis via coronary artery disease risk factors: a preliminary study. Cardiovasc J Afr 2007; 18: 165-8.
18. Karimi M, Haghighi AB, Yazdani M, Raisi H, Giti R, Namazee M. Is β-thalassemia trait a protective factor against ischemic carebrovascular accidents. J Stroke Cerebrovasc Dis 2008; 17: 79-81.
19. Tassiopoulos T, Stamatelos G, Zakopoulos N, Fessas P, Eliopoulos GD. Low incidence of acute mycardial infarction in β-thalassemia trait carriers. Haematologia (Budap) 1995; 26: 199-203.
20. Tassiopoulos S, Defterreos S, Konstantopoulos K, Farmakis D, Tsironi M, Kyriakidis M, Aessopos A. Does heterozygous β-thalassemia confer a protection against coronary artery disease? Ann N Y Acad Sci 2005; 1054: 467-70.
21. Wang CH, Shilling RF. Myocardial infarction and thalassemia trait: an example of heterozygote advantage. Am J Hematol 1995; 49: 73-5.
22. Karimi M, Bagheri H, Rastgu F, Rachmilewitz EA. Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with beta-thalassaemia intermedia. Thromb Haemost 2010; 103: 989-93.
23. Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A. Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost 2010; 8: 54-9.
24. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002; 99: 36-43.
25. Vyssoulis G, Karpanou E, Kyvelou SM, et al. Ambulatory blood pressure profile in hypertensive patients with β-thalassemia minor. Hypertens Res 2011; 34: 253-6.
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 8-12.